Soy isoflavones ameliorate the adverse effects of chemotherapy in children

Nutrition and Cancer

Volumn 62, Issue 7, 2010, Pages 1001-1005

  Tacyildiz, Nurdan ^a   Ozyoruk, Derya ^a   Yavuz, Gulsan ^a   Unal, Emel ^a   Dincaslan, Handan ^a   Dogu, Figen ^a   Sahin, Kazim ^b   Kucuk, Omer ^c  

^a ANKARA UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBOPLATIN; CARE FOOD VERTRIEB; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DAIDZEIN; DOXORUBICIN; ETOPOSIDE; GENISTEIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; IFOSFAMIDE; IRINOTECAN; MITOTANE; PACLITAXEL; PREDNISONE; PROCARBAZINE; TEMOZOLOMIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ABDOMINAL CANCER; ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADRENAL CORTEX TUMOR; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; INFECTION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUROBLASTOMA; PAIN; PILOT STUDY; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; GENISTEIN; HUMANS; MALE; NEOPLASMS; PILOT PROJECTS;

EID: 77957997925     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581.2010.509841     Document Type: Article

References (26)

1. Sarkar FH and Li Y: The role of isoflavones in cancer chemoprevention. Front Biosci 9, 2714-2724, 2004.
2. Zhou JR, Gugger ET, Tanaka T, Guo Y, Blackburn GL, et al.: Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. J Nutr 129, 1628-1635, 1999.
3. Hussain M, Banerjee M, Sarkar FH, Djuric Z, Pollak MN, et al.: Soy isoflavones in the treatment of prostate cancer. Nutr Cancer 47, 111-117, 2003.
4. Li Y, Kucuk O, Hussain M, Abrams J, Cher ML, et al.: Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/receptor activator of nuclear factor kappaB ligand (RANKL)/matrix metalloproteinase-9 (MMP-9) signaling in prostate cancer. Cancer Res 66, 4816-4825, 2006.
5. Li Y, Ahmed F, Ali S, Philip PA, Kucuk O, et al.: Inactivation of nuclear factor-kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res 65, 6934-6942, 2005.
6. Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, et al.: Anti-tumor activity of cisplatin is potentiated by soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer 1006, 1260-1268, 2006.
7. Khoshyomn S, Manske GC, Lew SM, Wald SL, and Penar PL: Synergistic action of genistein and cisplatin on growth inhibition and cytotoxicity of human medulloblastoma cells. Pediatr Neurosurg 33, 123-131, 2000.
8. Hillman GG, Forman JD, Kucuk O, Yudelev M, Maughan RL, et al.: Genistein potentiates radiation effect on prostate carcinoma cells. Clin Cancer Res 7, 382-390, 2001.
9. Hillman GG, Wang Y, Kucuk O, Che M, Doerge DR, et al.: Genistein potentiates inhibition of tumor growth by radiation in a prostate cancer orthotopic model. Mol Cancer Ther 3, 1271-1279, 2004.
10. Raffoul JJ, Banerjee S, Che M, Knoll ZE, Doerge DR, et al.: Soy isoflavones enhance radiotherapy in a metastatic prostate cancer model. Int J Cancer 120, 2491-2498, 2007.
11. Yashar CM, Spanos WJ, Taylor DD, and Gercel-Taylor C: Potentiation of the radiation effect with genistein in cervical cancer cells. Gynecol Oncol 99, 199-205, 2005.
12. Djuric Z, Chen G, Doerge D, Heilbrun L, and Kucuk O: Effect of soy supplementation on oxidative stress in men and women. Cancer Lett 172, 1-6, 2001.
13. Ruiz-Larrea MB, Mohan AR, Paganga G, Miller NJ, Bolwell GP, et al.: Antioxidant activity of phytoestrogenic isoflavones. Free Radic Res 26, 63-70, 1997.
14. Kapiotis S, Hermann M, Held I, Seelos C, Ehringer H, et al.: Genistein, the dietary-derived angiogenesis inhibitor, prevents LDL oxidation and protects endothelial cells from damage by atherogenic LDL. Arterioscler Thromb Vasc Biol 17, 2868-2874, 1997.
15. Blay M, Espinel AE, Delgado MA, Baiges I, Bladé C, et al.: Isoflavone effect on gene expression profile and biomarkers of inflammation. J Pharm Biomed Anal 51, 382-390, 2010.
16. Hall WL, Vafeiadou K, Hallund J, Bügel S, Koebnick C, et al.: Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr 82, 1260-1268, 2005.
17. Duan W, Kuo IC, Selvarajan S, Chua KY, Bay BH, et al.: Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 167, 185-192, 2003.
18. Park YJ, Jang YM, and Kwon YH: Isoflavones prevent endoplasmic reticulum stress-mediated neuronal degeneration tau hyperphosphorylation in SH-SY5Y cells. J Med Food 12, 528-535, 2009.
19. Kuzu N, Metin K, Dagli AF, Akdemir F, Orhan C, et al.: Protective role of genistein in acute liver damage induced by carbon tetrachloride. Mediators Inflamm, 2007. doi: 10.1155/2007/36381. (Pubitemid 351192841)
20. Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, et al.: Soy Isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutr Cancer. Forthcoming.
21. Piskula MK, Yamakoshi J, and Iwai Y: Daidzein and genistein but not their glucosides are absorbed from the rat stomach. FEBS Lett 447, 287-291, 1999.
22. Takimoto CH, Glover K, Huang X, Hayes SA, Gallot L, et al. Phase I pharmaco kinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev 12, 1213-1221, 2003.
23. Fischer L, Mahoney C, Jeffcoat AR, Koch MA, Thomas BE, et al.: Clinical characteristics and pharmacokinetics of purified soy isoflavones: multipledose administration to men with prostate neoplasia. Nutr Cancer 48, 160-170, 2004.
24. Kumar NB, Krischer JP, Allen K, Riccardi D, Besterman-Dahan K, et al.: A phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer. Nutr Cancer 59, 163-168, 2007.
25. Sakai T and Kogiso M: Soy isoflavones and immunity. J Med Invest 55, 167-173, 2008.
26. Andres A, Donovan SM, and Kuhlenschmidt MS: Soy isoflavones and virus infections. J Nutr Biochem 20, 563-569, 2009.